Last reviewed · How we verify
HRS-6209 in Combination with Letrozole
HRS-6209 in Combination with Letrozole is a Small molecule drug developed by Jiangsu HengRui Medicine Co., Ltd.. It is currently in Phase 1 development.
At a glance
| Generic name | HRS-6209 in Combination with Letrozole |
|---|---|
| Sponsor | Jiangsu HengRui Medicine Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study of HRS-6208 in Combination With HRS-8080, or Fulvestrant, or Letrozole, With or Without HRS-6209 in Patients With Advanced Unresectable or Metastatic Breast Cancer (PHASE1, PHASE2)
- To Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-6209 in Subjects With HR-Positive/HER2-Negative Solid Tumor (PHASE1)
- A Clinical Study of HRS-6209 Combined With Other Treatment Regimens in Patients With Breast Cancer (PHASE1, PHASE2)
- A Trial of HRS-6209 in Combination With Fulvestrant, Letrozole, HRS-8080, or HRS-1358 in Breast Cancer Patients (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- HRS-6209 in Combination with Letrozole CI brief — competitive landscape report
- HRS-6209 in Combination with Letrozole updates RSS · CI watch RSS
- Jiangsu HengRui Medicine Co., Ltd. portfolio CI
Frequently asked questions about HRS-6209 in Combination with Letrozole
What is HRS-6209 in Combination with Letrozole?
HRS-6209 in Combination with Letrozole is a Small molecule drug developed by Jiangsu HengRui Medicine Co., Ltd..
Who makes HRS-6209 in Combination with Letrozole?
HRS-6209 in Combination with Letrozole is developed by Jiangsu HengRui Medicine Co., Ltd. (see full Jiangsu HengRui Medicine Co., Ltd. pipeline at /company/jiangsu-hengrui-medicine-co-ltd).
What development phase is HRS-6209 in Combination with Letrozole in?
HRS-6209 in Combination with Letrozole is in Phase 1.